NIAID Media Roundtable: On the Frontlines of Flu Research

WHAT:	As concerns about the flu dominate the headlines, please join us as Anthony S. Fauci, M.D., NIAID director, briefs the media about frontline laboratory and clinical research, including future technologies for the development and manufacture of vaccines, including reverse genetics, cell-culture techniques and recombinant proteins NIAID-supported clinical trials to study herd immunity and the head-to-head efficacy of different vaccines new diagnostic techniques for rapidly detecting avian flu strains in the event of a pandemic The event will also serve to launch NIAID’s updated and expanded Focus on Flu Web site, spotlighting cutting-edge NIAID-supported research and graphics that illuminate concepts important to understanding influenza research such as reverse genetics and antigenic shift and drift. Following the briefing, Dr. Fauci and other NIAID staff will take questions from the audience.
WHO:	Anthony S. Fauci, M.D., NIAID director Brian Murphy, M.D., co-chief, NIAID Laboratory of Infectious Diseases Kanta Subbarao, M.D., senior investigator, Respiratory Viruses Section, NIAID Laboratory of Infectious Diseases Linda Lambert, Ph.D., acting chief, NIAID Division of Microbiology and Infectious Diseases (DMID), Influenza, SARS, and Related Viral Respiratory Diseases Section Cristina Cassetti, Ph.D., program officer, NIAID DMID Influenza, SARS, and Related Viral Respiratory Diseases Section Maria Giovanni, Ph.D., chief, NIAID DMID Genomics and Technology Development Section
WHEN:	Monday, Nov. 15, 10:30 - 11:30 a.m. Eastern Time
WHERE:	NIH Campus, Natcher Conference Center, Room E1/E2 Bethesda, MD Attendees are strongly encouraged to use the Metro. The NIH campus can be easily accessed via the Medical Center stop on the Metro’s Red Line. For information on transportation to and parking and security at NIH, go to http://www.nih.gov/about/visitorsecurity.htm.
REGISTER:	Advanced registration is requested. To register, contact Jennifer Wenger or Laurie K. Doepel at (301) 402-1663, or e-mail jwenger@niaid.nih.gov. Individuals with disabilities who need Sign Language Interpreters or reasonable accommodation to participate in this roundtable should contact Jennifer Wenger or Laurie K. Doepel. Such requests should be made at least 5 days in advance of the event.

NIAID is a component of the National Institutes of Health, an agency of the U.S. Department of Health and Human Services. NIAID supports basic and applied research to prevent, diagnose and treat infectious diseases such as HIV/AIDS and other sexually transmitted infections, influenza, tuberculosis, malaria and illness from potential agents of bioterrorism. NIAID also supports research on transplantation and immune-related illnesses, including autoimmune disorders, asthma and allergies. Press releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at http://www.niaid.nih.gov.